Medicare Enrolled

James Wallace

Medical Oncology · Chicago, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
5841 S MARYLAND AVE, Chicago, IL 60637
8888240200
Registered in NPPES since 2007
NPI: 1669687307 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Wallace from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Wallace? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Wallace

James Wallace is a medical oncology specialist in Chicago, IL, with 19 years of NPI registration. Based on federal Medicare data, Wallace performed 1,779 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Wallace received a total of $268,221 from 31 pharmaceutical and/or device companies across 321 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Wallace is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 30% volume in IL $268,221 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,779
Medicare services
Top 30% in IL for medical oncology
Not available
Unique patients (not deduplicated)
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,158 $97 $239
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
208 $65 $162
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
146 $142 $330
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
121 $99 $235
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
38 $141 $513
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
33 $107 $424
New patient office visit, complex (60-74 min) 26 $177 $466
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
20 $57 $163
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
16 $58 $163
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
13 $129 $374
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$268,221
Total received (2018-2024)
Avg $38,317/year across 7 years
Top 5% in IL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
321
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,780
2023
$41,071
2022
$38,331
2021
$26,047
2020
$12,720
2019
$73,750
2018
$61,522

Payments by company (2024)

JAZZ PHARMACEUTICALS INC.
$13,896
Novartis Pharmaceuticals Corporation
$288
PFIZER INC.
$95
Tempus AI, Inc
$93
SOBI, INC
$79
Gilead Sciences, Inc.
$69
AstraZeneca Pharmaceuticals LP
$58
E.R. Squibb & Sons, L.L.C.
$36
Genentech USA, Inc.
$27
Janssen Biotech, Inc.
$24
Daiichi Sankyo Inc.
$24
Astellas Pharma US Inc
$21
Alexion Pharmaceuticals, Inc.
$19
ABBVIE INC.
$19
EMD Serono, Inc.
$18
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 96.6% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$139,354
JAZZ PHARMACEUTICALS INC.
$113,773
Jazz Pharmaceuticals Inc.
$12,720
Boehringer Ingelheim Pharmaceuticals, Inc.
$416
Novartis Pharmaceuticals Corporation
$343
Gilead Sciences, Inc.
$217
Amgen Inc.
$214
AstraZeneca Pharmaceuticals LP
$195
PFIZER INC.
$125
Janssen Biotech, Inc.
$112
Tempus AI, Inc
$93
Cardinal Health 414 LLC
$82
SOBI, INC
$79
Merck Sharp & Dohme LLC
$48
Alexion Pharmaceuticals, Inc.
$44
Janssen Pharmaceuticals, Inc
$42
Myriad Genetic Laboratories, Inc.
$42
E.R. Squibb & Sons, L.L.C.
$36
Karyopharm Therapeutics Inc.
$30
Acrotech Biopharma Inc.
$28
Braintree Laboratories, Inc.
$27
Seagen Inc.
$26
Daiichi Sankyo Inc.
$24
AMAG Pharmaceuticals, Inc.
$24
MorphoSys, US Inc.
$22
Astellas Pharma US Inc
$21
ABBVIE INC.
$19
EMD Serono, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
Celgene Corporation
$18
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 99.1% of all-time payments
Associated products mentioned in payments ›
Alecensa · Aliqopa · BELEODAQ · BOSULIF · CALQUENCE · DARZALEX · Enhertu · Erleada · FERAHEME · GILOTRIF · IBRANCE · IMFINZI · INLYTA · KEYTRUDA · KISQALI · Kyprolis · LYNPARZA · MEKINIST · MONJUVI · Nplate · OJJAARA · OPDIVO · OXBRYTA · PADCEV · PLUVICTO · Padcev · Perjeta · Pomalyst · ROZLYTREK · RYBREVANT · SCEMBLIX · SOLIRIS · SUTAB · SUTENT · TECENTRIQ · Trodelvy · ULTOMIRIS · VENCLEXTA · VONJO · Venclexta · XALKORI · XARELTO · XPOVIO · ZEPZELCA · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical oncology specialist in Chicago?
Compare medical oncologists in the Chicago area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists in nearby ZIP areas
77
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
THE UNIVERSITY OF CHICAGO MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Wallace is a clinical cardiology specialist, with above-average Medicare volume (top 30% in IL), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Wallace experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Wallace performed 1,158 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Wallace receive payments from pharmaceutical companies?
Yes. Wallace received a total of $268,221 from 31 companies across 321 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Wallace's costs compare to other medical oncologists in Chicago?
Wallace's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Wallace) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →